Breast Cancer Clinical Trials in Illinois

Showing 521-540 of 578 trials

Gabapentin For the Control of Hot Flashes in Women With Breast Cancer

NCT00022074

RATIONALE: Gabapentin may be effective for the control of hot flashes. It is not yet known if gabapentin is effective in treating hot flashes. PURPOSE: Randomized clinical trial to study the effectiveness of gabapentin in controlling hot flashes in women who have breast cancer.

Anxiety DisorderBreast CancerDepression+1 more

Gary MorrowStarted Jul 2001

Mobile, Alabama, United States • Phoenix, Arizona, United States • Scottsdale, Arizona, United States +15 more locations

TERMINATEDPhase 351 miles

To Compare Treatment With Doxorubicin or Capecitabine for Metastatic Breast Cancer in Women 60 Years and Older

NCT00082095

The main purpose of this study is to compare treatment with either pegylated liposomal doxorubicin or capecitabine as first line chemotherapy for metastatic breast cancer in women 60 years and older.

Metastatic Breast Cancer

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.62 participantsStarted Apr 2004

Fountain Valley, California, United States • Oxnard, California, United States • Soquel, California, United States +24 more locations

Gabapentin For the Control of Hot Flashes in Women With Breast Cancer

To Compare Treatment With Doxorubicin or Capecitabine for Metastatic Breast Cancer in Women 60 Years and Older

Breast Cancer Trials in Other Cities

Panitumumab, Gemcitabine and Carboplatin in Triple-Negative Metastatic Breast Cancer

Neoadjuvant Ixabepilone/Carboplatin/Trastuzumab in HER2-Positive Locally Advanced Breast Cancer

Phase I/II Trial of Sorafenib Plus Ixabepilone in HER2-Negative Metastatic Breast Cancer

Continued Efficacy and Safety of Zoledronic Acid (q 4 Wks vs. q 12 Wks) in the 2nd Year of Treatment in Patients With Bone Metastases From Breast Cancer

A Study of Trastuzumab Emtansine (T-DM1) Sequentially With Anthracycline-based Chemotherapy, as Adjuvant or Neoadjuvant Therapy for Patients With Early Stage Herceptin (HER)2-positive Breast Cancer

1st or 2nd Line MBC (Metastatic Breast Cancer) With Previous Avastin (Bevacizumab) Therapy

Thyroid Dysfunction in Women With Newly Diagnosed Breast Cancer Compared to Healthy Volunteers

Efficacy and Safety of Gadobutrol 1.0 Molar (Gadovist) for Breast Magnetic Resonance Imaging (MRI)

Hormone Receptor Positive Metastatic Breast Cancer (HR+ mBC) BIIB021 Plus Aromasin Schedule Finding

Neoadjuvant Tipifarnib, Docetaxel, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIA or Stage IIIB Breast Cancer

Letrozole, Herceptin in Her2neu +, Estrogen Receptor [ER] and/or Progesterone Receptor [PR] Positive, MBC

Vorinostat and Trastuzumab in Treating Patients With Metastatic or Locally Recurrent Breast Cancer

OctavaPink for Women With Dense Breast After Negative Mammography

Breast Cancer Biomarker Sample Collection for the dtectDx Assay Verification

MarginProbe, a Device for Intraoperative Assessment of Margin Status in Breast Conservation Surgery

A Study of Avastin (Bevacizumab) in Combination With Herceptin (Trastuzumab)/Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.

Randomized Study of Combination Chemotherapy With or Without Focused Microwave Thermotherapy Before Surgery in Treating Women With Large Breast Cancer Tumors

Safety Study of XL647 and XL147 Administered in Combination Daily in Adults With Solid Tumors

Other Conditions in Illinois